{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:10:59Z","timestamp":1790111459629,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ygyno.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T20:10:18Z","timestamp":1519935018000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":123,"title":["Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-7311","authenticated-orcid":false,"given":"Mie","family":"Jareid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Thalabard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Aarflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege M.","family":"B\u00f8velstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiliv","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje","family":"Braaten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ygyno.2018.02.006_bb0005","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2018.02.006_bb0010","series-title":"GLOBOCAN 2012 v1.0, Cancer Incidence And Mortality Worldwide: IARC CancerBase No. 11","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.ygyno.2018.02.006_bb0015","author":"SEER"},{"key":"10.1016\/j.ygyno.2018.02.006_bb0020","series-title":"Cancer in Norway 2015 - Cancer Incidence, Mortality, Survival and Prevalence in Norway","author":"Cancer Registry of Norway","year":"2016"},{"issue":"10","key":"10.1016\/j.ygyno.2018.02.006_bb0025","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/cncr.30528","article-title":"Risk-reducing salpingectomy: let us be opportunistic","volume":"123","author":"Long Roche","year":"2017","journal-title":"Cancer"},{"issue":"9609","key":"10.1016\/j.ygyno.2018.02.006_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","article-title":"Reproductive risk factors and endometrial cancer: the European prospective investigation into cancer and nutrition","volume":"127","author":"Dossus","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"9017","key":"10.1016\/j.ygyno.2018.02.006_bb0040","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.ygyno.2018.02.006_bb0045","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"M\u00f8rch","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2018.02.006_bb0050","series-title":"Report No.: Evidence Report\/Technology Assessment No. 212","article-title":"Oral contraceptive use for the primary prevention of ovarian cancer","author":"Havrilesky","year":"2013"},{"issue":"1","key":"10.1016\/j.ygyno.2018.02.006_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/aogs.13055","article-title":"Contraceptive use in the Nordic countries","volume":"96","author":"Lindh","year":"2017","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2018.02.006_bb0060","first-page":"1","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","author":"Soini","year":"2016","journal-title":"Acta Oncol."},{"issue":"2 Pt 1","key":"10.1016\/j.ygyno.2018.02.006_bb0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/AOG.0000000000000356","article-title":"Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland","volume":"124","author":"Soini","year":"2014","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0070","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/0284186X.2015.1062538","article-title":"Levonorgestrel-releasing intrauterine system and the risk of breast cancer: a nationwide cohort study","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2018.02.006_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/1471-0528.12499","article-title":"Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial","volume":"121","author":"Orbo","year":"2014","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.ygyno.2018.02.006_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ije\/dym137","article-title":"Cohort profile: the Norwegian women and cancer study--NOWAC--Kvinner og kreft","volume":"37","author":"Lund","year":"2008","journal-title":"Int. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.ygyno.2018.02.006_bb0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1023\/B:CACO.0000007982.18311.2e","article-title":"External validity in a population-based national prospective study--the Norwegian women and cancer study (NOWAC)","volume":"14","author":"Lund","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2018.02.006_bb0090","series-title":"World Cancer Report 2014","year":"2014"},{"issue":"3","key":"10.1016\/j.ygyno.2018.02.006_bb0095","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.annepidem.2010.10.002","article-title":"Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer","volume":"21","author":"Ness","year":"2011","journal-title":"Ann. Epidemiol."},{"issue":"10","key":"10.1016\/j.ygyno.2018.02.006_bb0100","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1002\/ijc.24232","article-title":"Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006","volume":"124","author":"Dorjgochoo","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2018.02.006_bb0105","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s10552-013-0296-8","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.ygyno.2018.02.006_bb0110","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/humrep\/der211","article-title":"The \u2018incessant menstruation\u2019 hypothesis: a mechanistic ovarian cancer model with implications for prevention","volume":"26","author":"Vercellini","year":"2011","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.ygyno.2018.02.006_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case\u2013control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.02.006_bb0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2018.02.006_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/humupd\/dmn003","article-title":"Intrauterine devices and intrauterine systems","volume":"14","author":"ESHRE Capri Workshop Group","year":"2008","journal-title":"Hum. Reprod. Update"},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01987274","article-title":"Ovarian function after seven years' use of a levonorgestrel IUD","volume":"11","author":"Barbosa","year":"1995","journal-title":"Adv. Contracept."},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years 1 1Mirena is a registered trademark of Leiras Oy, Turku, Finland","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"issue":"23","key":"10.1016\/j.ygyno.2018.02.006_bb0140","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Risch","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.ygyno.2018.02.006_bb0145","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2004.07.961","article-title":"Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel","volume":"83","author":"Lockhat","year":"2005","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.ygyno.2018.02.006_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jnci\/94.1.50","article-title":"Progestin-induced apoptosis in the macaque ovarian epithelium: differential regulation of transforming growth factor-beta","volume":"94","author":"Rodriguez","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ygyno.2018.02.006_bb0160","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/sj.bjc.6601715","article-title":"Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's lifestyle and health cohort study","volume":"90","author":"Kumle","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2018.02.006_bb0165","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1002\/ijc.29229","article-title":"Intrauterine devices and endometrial cancer risk: a pooled analysis of the epidemiology of endometrial cancer consortium","volume":"136","author":"Felix","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2018.02.006_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13058-016-0798-x","article-title":"Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program","volume":"19","author":"Ellingjord-Dale","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2018.02.006_bb0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10552-015-0702-5","article-title":"Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment","volume":"27","author":"Heikkinen","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.ygyno.2018.02.006_bb4000","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-5868-9-2","article-title":"Criterion validity of a 10-category scale for ranking physical activity in Norwegian women","volume":"9","author":"Borch","year":"2012","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"10.1016\/j.ygyno.2018.02.006_bb4100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/CLEP.S83839","article-title":"Validity of self-reported body mass index among middle-aged participants in the Norwegian Women and Cancer study","volume":"7","author":"Skeie","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ygyno.2018.02.006_bb4200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6874-8-1","article-title":"Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancerpostgenome cohort - a cross-sectional analysis","volume":"8","author":"Waaseth","year":"2008","journal-title":"BMC Womens Health"},{"issue":"13","key":"10.1016\/j.ygyno.2018.02.006_bb0180","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818301252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818301252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:04:22Z","timestamp":1719842662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818301252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0090825818301252"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.02.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}